Clinical Trials Logo
  1. Home
  2. Condylomata Acuminata
  3. NCT00449982

Efficacy and Safety Study of Polyphenon E to Treat External Genital Warts

Condylomata Acuminata Clinical Trial

Official title:
A Randomized, Double-Blind, Three-Arm Parallel-Group, Placebo-Controlled Phase 3 Trial to Investigate the Clinical Efficacy and Safety of Polyphenon E in the Treatment of External Genital Warts

Clinical Trial Summary

The purpose of this study is to investigate the clinical efficacy, safety and tolerability of a Polyphenon E Ointment 10% and a Polyphenon E Ointment 15% in the treatment of external genitial warts in male and female patients.

Clinical Trial Description

External genital warts are non-malignant tumors caused by infections of the human papillomavirus (HPV), mainly types 6 and 11. Genital wart infections have one of the fastest growing incidence rates of all sexually transmitted diseases, with about 1% of sexually active adults in the United States suffering from this infection and at least 15% with subclinical infection. None of the current treatment options (with exception of interferon) has been subjected to controlled prospective clinical trials, although they are generally regarded as safe and effective. However, one of their major disadvantages is that they are painful and may cause scarring. Additionally recurrence of warts can often be observed. Against this background the study tries to evaluate another effective and well tolerated therapeutic option by using an extract of green tea leaves.

Comparison: Polyphenon E Ointment 10%, Polyphenon E Ointment 15%, placebo ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00449982
Study type Interventional
Source MediGene
Contact
Status Completed
Phase Phase 3
Start date July 2003
Completion date August 2004
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04537156 - Efficacy, Immunogenicity and Safty Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) Phase 3
Completed NCT00090285 - An Investigational Study of Gardasil™ (qHPV Vaccine) in Reducing the Incidence of Anogenital Warts in Young Men (V501-020) Phase 3
Completed NCT00973856 - Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands N/A
Completed NCT02015260 - A Trial of the Efficacy and Safety of Topical Nitric Oxide in Patients With Anogenital Warts Phase 2
Active, not recruiting NCT05056402 - An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old Phase 3
Withdrawn NCT00365443 - Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003) Phase 2
Not yet recruiting NCT01483794 - Epidemiology, Costs and Psychosocial Consequences of Genital Warts in Valparaiso, Chile N/A
Completed NCT03935204 - Immunogenicity Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) Phase 2
Completed NCT02405520 - Safety and Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine Phase 1
Active, not recruiting NCT02710851 - Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine Phase 2
Completed NCT04782895 - Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil®9 in Healthy Females 18-26 Years of Age Phase 3
Completed NCT03546842 - Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017) Phase 3
Completed NCT03981822 - A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts Phase 2
Recruiting NCT03158480 - Safety and Efficacy of Immune Therapy for Condyloma N/A
Completed NCT01598779 - Human Papillomavirus (HPV) Types Present in External Genital Warts (EGW) in the Argentinean Population N/A
Completed NCT03813940 - Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) Phase 1
Not yet recruiting NCT06197802 - Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women
Completed NCT01532102 - Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts Phase 1/Phase 2
Active, not recruiting NCT06297187 - Cavitronic Ultrasonic Surgical Aspiration (CUSA) Women's Health Study
Not yet recruiting NCT03853785 - Efficacy of Intralesional MMR Vaccine,Intralesional Candidal Antigen&Topical Podophyllin in Treatment of Genital Warts Phase 3